Cas:14271-86-4 1-Naphthoyl Cyanide manufacturer & supplier

Chemical Name:1-Naphthoyl Cyanide

CAS.NO:14271-86-4

Synonyms:1-NAPHTHOYL CYANIDE;naphthalene-1-carbonyl cyanide;1-Naphthalenecarbonyl Cyanide

Molecular Formula:C₁₂H₇NO

Molecular Weight:181.19000

HS Code:2926909090

Physical and Chemical Properties:

Melting point:100ºC

Boiling point:182ºC / 15mmHg

Density:1.22g/cm3

Index of Refraction:1.648

PSA:40.86000

Exact Mass:181.05300

LogP:2.54608

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-NAPHTHOYL CYANIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Naphthalenecarbonyl Cyanide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,naphthalene-1-carbonyl cyanide Use and application,1-NAPHTHOYL CYANIDE technical grade,usp/ep/jp grade.

Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1-Naphthoyl Cyanide manufacturer A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening. 1-Naphthoyl Cyanide supplier The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. 1-Naphthoyl Cyanide vendor The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 1-Naphthoyl Cyanide factory The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said.